Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 28;21(21):8021. doi: 10.3390/ijms21218021

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Positron emission computed tomography scan images. (A,D): Baseline. (B,E): Partial response (PR) of the patient after 2 months of treatment with trametinib. (C,F): Progression disease (PD) after 10 months of treatment. Arrows indicate the target lesions. Size and standardized uptake value max (SUVmax) of the two main lesions, peritoneal and left axillary subcutaneous lesion at the different stages, respectively: (A,D): 2.4 cm/SUV 8.4 and 2 cm/SUV 4.7; (B,E): 2.4 cm/SUV 4.5 and 1.5 cm/SUV 3.7; (C,F): 6.3 cm/12.2 and 2.1 cm/SUV 4.8.